Our team developed this article to describe some of the insights of the Direct to Consumer model, potential benefits, early adopters, unknowns, and how it ties into overall MFN and GENEROUS model readiness along with all the impacts to various processes and internal systems.

Marbls partners with pharmaceutical and medical device and diagnostic manufacturers to provide practical, innovative services that address complex pricing, contracting and commercial excellence needs — driving the path of critical drugs, devices, and diagnostics to market. We invest in the long-term success of our clients by investing in our employees. As a team with world-class experience and a client-first philosophy, we create long term relationships based on success, service and trust. Our approach is results driven, hands-on and flexible to address the unique internal and external dynamics impacting our clients.